Furthermore, MortaparibPlus-induced cancer cell death occurs through multiple mechanisms, including the inhibition of PARP-1, upregulation of p73, and the downregulation of mortalin and CARF proteins that play critical roles in carcinogenesis. This evidence concerns the gene HSPA9 and cancer.